Carcinoma, Squamous Cell: all 1,779 studies
Page 4 of 18. Open to participants first (409), then studies with results posted, then the rest; newest registration first within each.
- Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell CarcinomaRecruitingNCT05637268Phase 2
- Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCCRecruitingNCT05626569Phase 2
- Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance TechnologiesRecruitingNCT05611515
- Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer PatientsRecruitingNCT05596890Phase 2
- AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell CarcinomaNot yet recruitingNCT05594914Phase 2
- Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal CancersNot yet recruitingNCT05582590Phase 1
- Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I)RecruitingNCT05582265Phase 3
- Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell CarcinomaRecruitingNCT05515315Phase 2
- Concurrent Chemoradiotherapy for Stage IVB Esophageal Squamous Cell Carcinoma（EC-CRT-003）RecruitingNCT05512520Phase 2
- Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCCRecruitingNCT05507411Phase 2
- Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT05495152Phase 3
- A Phase II Study of CRT Combined With QL1706 in ESCC PatientsRecruitingNCT05490719Phase 2
- Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell CarcinomaRecruitingNCT05490485Phase 2
- A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected MalignanciesRecruitingNCT05473156Phase 1/2
- Detection of Oral and Throat Cancers Using OralViome Cancer Testing SystemRecruitingNCT05451303
- Conversion of Tislelizumab Combined With Chemotherapy in Unresectable Esophageal Squamous Cell CarcinomaRecruitingNCT05449483Phase 2
- Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCCRecruitingNCT05437380Not applicable
- Two-field Versus Three-field Lymph Node Dissection in ESCC After Neoadjuvant TherapyNot yet recruitingNCT05420480Not applicable
- SOTO: Treatment Sensitivity of Organoids to Predict Treatment OutcomeRecruitingNCT05400239
- Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCCRecruitingNCT05394415Phase 1/2
- Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx CancerRecruitingNCT05388773Phase 2
- Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma PatientsRecruitingNCT05374252Phase 3
- HYpofractionated, Dose-redistributed RAdiotherapy With Protons and Photons in HNSCCRecruitingNCT05364411Not applicable
- Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study.RecruitingNCT05333523Phase 3
- L19IL2/L19TNF in Skin Cancer PatientsRecruitingNCT05329792Phase 2
- Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell CancerNot yet recruitingNCT05322499Phase 2
- A Study of Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (PIPER)RecruitingNCT05286619Phase 2
- Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004)RecruitingNCT05281003Phase 2
- Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma PatientsRecruitingNCT05252078Phase 2
- Immune System Modulation and Outcome in High-risk cSCC Treated With Surgery and RadiotherapyNot yet recruitingNCT05246228
- Sintilimab Plus NCT or NCRT Versus NCRT for ESCCNot yet recruitingNCT05244798Phase 3
- Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT05214222Phase 2
- Basal Cell Carcinoma Chemoprevention TrialRecruitingNCT05212246Phase 3
- Artificial Intelligence in Functional Imaging for Individualized Treatment of Head and Neck Squamous Cell Carcinoma PatientsRecruitingNCT05192655
- Study of Camrelizumab in Combination With Apatinib Mesylate Plus Albumin-bound Paclitaxel and Cisplatin as the First Line Treatment of Recurrent or Metastatic, UnresectableHead and Neck Squamous Cell CarcinomaNot yet recruitingNCT05189184Phase 2
- Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric CancerRecruitingNCT05163483Phase 2
- RAPA-201 Therapy of Solid TumorsRecruitingNCT05144698Phase 1/2
- Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCCRecruitingNCT05125055Phase 2/3
- Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and NeckRecruitingNCT05108090Not applicable
- Spectroscopic Analysis of Tongue Tumor Samples.RecruitingNCT05104619
- Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)RecruitingNCT05098119Phase 2
- Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC PatientsRecruitingNCT05069857Phase 2
- Neoadjuvant DaRT for Locally Advanced Oral Cavity SCCNot yet recruitingNCT05065346Not applicable
- Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCCRecruitingNCT05047094Not applicable
- Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)RecruitingNCT05044117Phase 3
- Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous CarcinomaNot yet recruitingNCT05039606Phase 2
- Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell CarcinomaRecruitingNCT05030597
- Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)RecruitingNCT05027633Phase 2
- Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell CarcinomaRecruitingNCT05025813Phase 2
- Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After SurgeryNot yet recruitingNCT05024019Phase 2
- ALK Tyrosine Kinase Inhibitors in ALK-rearranged Advanced Squamous Cell CarcinomaRecruitingNCT05014464Phase 2
- A Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCCRecruitingNCT04992559Phase 2
- Study of Nimotuzumab Combined With IMRT in Elder Patients With Cervical Squamous Cell CarcinomaNot yet recruitingNCT04976478
- Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCCRecruitingNCT04973306Phase 2/3
- SHR-1701 Combined With Fluzoparib in Lung Squamous Cell CarcinomaRecruitingNCT04937972Phase 2
- Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck CancerRecruitingNCT04915183Phase 2
- JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCCRecruitingNCT04892173Phase 3
- Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent TumorsNot yet recruitingNCT04889742Phase 2
- Camrelizumab as a Maintenance Therapy After Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT04861467Phase 2
- Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in ChinaRecruitingNCT04857164Phase 2
- Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)RecruitingNCT04807673Phase 3
- A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva CancerRecruitingNCT04761146Not applicable
- Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck CancersRecruitingNCT04747054Phase 3
- Toripalimab Combined With Chemotherapy in Primary Tracheal Squamous Cell CarcinomaNot yet recruitingNCT04716751Phase 2
- Dose De-escalation and Sentinel LN Mapping Driven Radiotherapy of Contralateral Neck in Ipsilateral Node Positive HNSCCRecruitingNCT04688528Not applicable
- Induction and Maintenance Treatment With PARP Inhibitor and Immunotherapy in HPV-negative HNSCCRecruitingNCT04681469Phase 2
- Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell CarcinomaNot yet recruitingNCT04678791Not applicable
- A Randomized, Double-blind Study to Evaluate the Clinical Effect and Safety of Fucoidan in Patients With Squamous Cell Carcinomas of the Head and NeckRecruitingNCT04597476Phase 2
- Specific Methylation Profiles in HNSCCRecruitingNCT04567056
- Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCCRecruitingNCT04564989
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue NeoplasiaRecruitingNCT04534127Not applicable
- Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)RecruitingNCT04519905Not applicable
- TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapYRecruitingNCT04481256Not applicable
- Proton Versus Photon Therapy in Anal Squamous Cell CarcinomaRecruitingNCT04462042Not applicable
- Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal CancerRecruitingNCT04460352Phase 3
- Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal CancerRecruitingNCT04444869Phase 2
- Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid TumorsRecruitingNCT04429542Phase 1
- A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT04370587Phase 1/2
- A Randomized Controlled Trial Evaluating of Prophylactic Irradiation in CRT for cT1bN0M0 ESCCRecruitingNCT04328948Phase 3
- RISI in the Treatment of Recurrent Metastatic SCC of Thoracic Inlet Lymph NodesRecruitingNCT04266327Not applicable
- IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell CarcinomasRecruitingNCT04224389
- Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell CarcinomaRecruitingNCT04220749Phase 2
- Nivolumab for Treatment of Squamous Cell Carcinoma of the SkinRecruitingNCT04204837Phase 2
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)RecruitingNCT04198766Phase 1/2
- Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)RecruitingNCT04138212Phase 3
- Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell CarcinomaRecruitingNCT04135664Phase 3
- p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)RecruitingNCT04104945Not applicable
- Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell CarcinomaRecruitingNCT04099290
- Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous TumorsRecruitingNCT04068155Not applicable
- VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx CancerRecruitingNCT04057209Not applicable
- Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal CancerRecruitingNCT04018872Phase 2
- Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal CarcinomaRecruitingNCT04009265Phase 3
- Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT03964753Phase 2
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.RecruitingNCT03889899Not applicable
- Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And NeckRecruitingNCT03830385Phase 2
- Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell CarcinomaRecruitingNCT03815903Phase 3
- A Phase II Exploratory Clinical Trial of Multiple Drug Combinations in the Treatment of Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT03736863Phase 2
- Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma With Neoadjuvant ChemoradiotherapyRecruitingNCT03734952Not applicable
- Epidermoid Cancer Development in Esophageal AchalasiaRecruitingNCT03546998
- Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell CarcinomaRecruitingNCT03406247Phase 2